Sugarbreak is a technology company.
Sugarbreak has raised $3.0M across 1 funding round.
Sugarbreak has raised $3.0M in total across 1 funding round.
Sugarbreak has raised $3.0M in total across 1 funding round.
Sugarbreak's investors include BBG Ventures, Bronze Investments, Red Swan Ventures, StartHer, True Ventures, XFactor Ventures, Agneta Breitenstein, Bianca Ambrosini.
Sugarbreak is a Public Benefit Corporation (PBC) developing natural, non-prescription products to help consumers curb sugar intake and manage blood sugar levels, targeting the widespread issue of pre-diabetes and diabetes affecting one in three Americans, 80% of whom are unaware.[1][4][5] Its flagship offerings include supplements like the Resist line, with retail presence in major chains such as Target and CVS alongside a robust e-commerce operation, and upcoming expansions into pre-exercise electrolyte powder, sugar-craving gum, and the first U.S. saliva glucose swab.[1] Sugarbreak serves health-conscious individuals seeking accessible blood sugar management without prescriptions, solving the problem of high sugar consumption and undiagnosed blood sugar issues by prioritizing mission-driven education and ease of use over pure financial returns.[1][5]
The company demonstrates strong growth momentum through rapid retail expansion post-launch and product line diversification in its early years, aiming to make blood sugar health "front of mind" and combat the diabetes epidemic via measurable, feel-good benefits.[1]
Sugarbreak was founded around 2021 by Scarlett Leung, who serves as co-founder and CEO, with the company entering its second year of business by early 2022.[1][3] Operating as a PBC from inception, it was headquartered at 907 Broadway, 4th Floor in New York, reflecting its roots in the New York tech scene where Leung was highlighted as one of five female founders changing the face of local tech.[1][3] The idea emerged from a mission to address the diabetes crisis accessibly—using natural ingredients for sugar reduction and blood sugar support—prioritizing public benefit in its corporate structure to ensure decisions serve health goals first.[1][5]
Early traction came swiftly with a PR launch positioning it as "the first all-natural solution" for sugar reduction, followed by retail partnerships with Target and CVS, and plans for innovative product extensions signaling pivotal momentum in consumer health.[1][5]
Sugarbreak rides the wave of food tech innovations targeting sugar reduction amid rising diabetes rates, aligning with trends like enzymatic sugar conversion (e.g., Zya's Convero) and absorption "sponges" (e.g., BioLumen's Monch Monch), though it differentiates via natural supplements rather than tech-heavy additives.[2] Timing is ideal as consumer awareness grows post-pandemic, with brick-and-mortar shifting to experiential retail and demand for non-prescription health tools surging—major producers like Kraft Heinz seek sugar alternatives, creating tailwinds for accessible solutions.[1][2] Market forces favoring natural wellness, FDA pathways for supplements, and PBC models amplify its influence, positioning Sugarbreak to educate on blood sugar while contributing to a startup ecosystem blending tech, health, and retail.[1][2][5]
Sugarbreak is poised for accelerated growth through its 2022-announced expansions and retail foothold, potentially capturing more share in the $50B+ U.S. diabetes management market as saliva testing and craving-focused products gain traction.[1] Trends like personalized nutrition tech and sugar-reduction mandates will shape its path, with PBC status ensuring sustained mission focus amid investor interest (evidenced by early SEC filings).[3] Its influence may evolve from niche educator to ecosystem shaper, partnering with food makers or expanding diagnostics, ultimately empowering widespread blood sugar awareness as promised in its founding vision.[1][5]
Sugarbreak has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in November 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2020 | $3.0M Seed | BBG Ventures, Bronze Investments, Red Swan Ventures, StartHer, True Ventures, XFactor Ventures, Agneta Breitenstein, Bianca Ambrosini |